This Research Topic is part of a series with:
Discovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and MechanismsDiscovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and Mechanisms - Volume IINatural products are complex and rich in structure and have extensive biological activities, which are important sources of new drug creation. Vincristine, Camptothecin and Paclitaxel are all well-known anticancer drugs discovered through activity-oriented isolation, activity screening and structural modification. Antitumor drugs with novel structures derived from natural products and their derivatives are a hot field of tumor drug development, and it is a supplement to organic synthesis and combinatorial chemistry. It is also an effective way to find new anticancer drugs to search for anti-cancer lead compounds with enzymes, receptors and genes as new molecular targets. The target study of natural products is very important to elucidate the mechanism of drug action and the research and development of new drugs. Many small molecules exert corresponding pharmacological effects by acting on multiple targets. It is very difficult to find the direct targets of active natural products, but the methods and techniques of natural product target identification have made great progress.
The goal of this Research Topic is to use more direct and efficient means to find small molecule lead compounds with anticancer activity. The direct targets of small molecule compounds can be found by target recognition technology, and the mechanism of action can be elucidated. At the same time, novel small-molecule lead compounds can also catch more potential anticancer targets and mechanisms. It can provide more possibilities for the discovery of new anticancer drugs. The topics we are interested in covering include:
1. New technology and application of guided separation of anticancer active compounds.
2. Anticancer targets and mechanisms of natural anticancer products and their structural modifiers.
3. Discovery of novel anticancer lead compounds with novel structures.
4. Application of target recognition technology in the determination of direct target of natural anticancer products.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
This Research Topic is part of a series with:
Discovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and MechanismsDiscovery of Small Molecule Lead Compounds: a Driving Force to Unravel New Anti-Cancer Targets and Mechanisms - Volume IINatural products are complex and rich in structure and have extensive biological activities, which are important sources of new drug creation. Vincristine, Camptothecin and Paclitaxel are all well-known anticancer drugs discovered through activity-oriented isolation, activity screening and structural modification. Antitumor drugs with novel structures derived from natural products and their derivatives are a hot field of tumor drug development, and it is a supplement to organic synthesis and combinatorial chemistry. It is also an effective way to find new anticancer drugs to search for anti-cancer lead compounds with enzymes, receptors and genes as new molecular targets. The target study of natural products is very important to elucidate the mechanism of drug action and the research and development of new drugs. Many small molecules exert corresponding pharmacological effects by acting on multiple targets. It is very difficult to find the direct targets of active natural products, but the methods and techniques of natural product target identification have made great progress.
The goal of this Research Topic is to use more direct and efficient means to find small molecule lead compounds with anticancer activity. The direct targets of small molecule compounds can be found by target recognition technology, and the mechanism of action can be elucidated. At the same time, novel small-molecule lead compounds can also catch more potential anticancer targets and mechanisms. It can provide more possibilities for the discovery of new anticancer drugs. The topics we are interested in covering include:
1. New technology and application of guided separation of anticancer active compounds.
2. Anticancer targets and mechanisms of natural anticancer products and their structural modifiers.
3. Discovery of novel anticancer lead compounds with novel structures.
4. Application of target recognition technology in the determination of direct target of natural anticancer products.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.